MAPT and Alzheimer disease: The combined data indicate that the APPNL-G-F/MAPTP301S mouse model recapitulates many of the pivotal neuroinflammatory features of AD, and also suggest that the accumulation of Aβ is a stronger driver of microglial activation and astrogliosis that MAPT pathology.